Entellus Medical, Inc.
(NASDAQ : ENTL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.55%92.670.6%$508.26m
ABTAbbott Laboratories
-0.33%68.840.8%$467.50m
ALGNAlign Technology, Inc.
3.20%216.836.3%$454.89m
ISRGIntuitive Surgical, Inc.
1.33%491.702.4%$452.15m
TMOThermo Fisher Scientific Inc.
0.69%235.011.0%$440.86m
BAXBaxter International Inc.
1.47%65.121.7%$330.99m
BDXBecton, Dickinson and Company
1.52%243.001.1%$324.99m
BSXBoston Scientific Corporation
2.41%34.871.1%$289.08m
EWEdwards Lifesciences Corporation
-0.37%149.041.2%$265.46m
ABMDABIOMED, Inc.
0.53%303.893.3%$252.04m
SYKStryker Corporation
-0.71%164.771.3%$236.83m
DXCMDexCom, Inc.
1.56%121.708.5%$186.91m
ZBHZimmer Biomet Holdings, Inc.
0.33%112.771.7%$143.77m
WATWaters Corporation
0.66%197.383.5%$137.62m
XRAYDENTSPLY International Inc.
0.38%37.063.1%$129.02m

Company Profile

Entellus Medical, Inc. is a medical technology company focused on the design, development and commercialization of products for the treatment of chronic sinusitis. Its XprESS family of products is used by ear, nose and throat, physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation to treat patients with symptomatic inflammation of the nasal sinuses. Entellus Medical was founded by Thomas V. Ressemann and Peter Keith in April 2006 and is headquartered in Plymouth, MN.